Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glasdegib plus chemotherapy vs chemotherapy alone in untreated acute myeloid leukemia
CTR20181749Phase 3Terminated
- Sponsor
- Pfizer
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of glasdegib in acute myeloid leukemia (AML), sponsored by Pfizer. Started Jan 2019; status: terminated.
02
Drugs
glasdegib
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on CTR20181749.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20181749.